2009Modern Medicine HealthRequires access

Effect of different doses of losartan on treatment of diabetic nephropathy

Cheng De-zheng

Open publisher page 0 citations

Abstract

Objective:To explore the effects of different doses of losartan on the treatment of diabetic nephropathy.Methods:120 cases of diabetic kidney were randomly divided into three groups for strict diabetes treatment.Group A,B and C were given losartan in a dose of 25,50,100 mg/(time.d) respectively.After 8-week treatment,serum creatinine(SCr),urinary albumin excretion rate(UAER),crea-tinine clearance rate(CCr) and lipids were detected in three groups.Results:After treatment,UAER,TC and TG were reduced significantly in the three groups(P0.05);between group B and A,group C and A the differences were statistically significant(P0.05);However,group B and C had no statistically significant difference.SCr in three groups before and after treatment had no statistical difference.The level of CCr had statistical differences before and after treatment(P0.05),but group C and A had statistical difference(P0.05).Conclusion: Losartan is safe,effective and well tolerated with no significant adverse reactions for treating diabetic nephropathy.

About this research paper

What this paper is about

Objective:To explore the effects of different doses of losartan on the treatment of diabetic nephropathy.Methods:120 cases of diabetic kidney were randomly divided into three groups for strict diabetes treatment.Group A,B and C were given losartan in a dose of 25,50,100 mg/(time.d) respectively.After 8-week treatment,serum creatinine(SCr),urinary albumin excretion rate(UAER),crea-tinine clearance rate(CCr) and lipids were detected in three groups.Results:After treatment,UAER,TC and TG were reduced significantly in the three groups(P0.05);between group B and A,group C and A the differences were statistically significant(P0.05);However,group B and C had no statistically significant difference.SCr in three groups before and after treatment had no statistical difference.The level of CCr had statistical differences before and after treatment(P0.05),but group C and A had statistical difference(P0.05).Conclusion: Losartan is safe,effective and well tolerated with no significant adverse reactions for treating diabetic nephropathy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the effects of different doses of losartan on the treatment of diabetic nephropathy.Methods:120 cases of diabetic kidney were randomly divided into three groups for strict diabetes treatment.Group A,B and C were given losartan in a dose of 25,50,100 mg/(time.d) respectively.After 8-week treatment,serum creatinine(SCr),urinary albumin excretion rate(UAER),crea-tinine clearance rate(CCr) and lipids were detected in three groups.Results:After treatment,UAER,TC and TG were reduced significantly in the three groups(P0.05);between group B and A,group C and A the differences were statistically significant(P0.05);However,group B and C had no statistically significant difference.SCr in three groups before and after treatment had no statistical difference.The level of CCr had statistical differences before and after treatment(P0.05),but group C and A had statistical difference(P0.05).Conclusion: Losartan is safe,effective and well tolerated with no significant adverse reactions for treating diabetic nephropathy.

Key concepts: Medicine, Losartan, Diabetic nephropathy, Urology, Creatinine, Diabetes mellitus, Internal medicine, Excretion

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of different doses of losartan on treatment of diabetic nephropathy — Research Paper | ScholarLens